1. Adelaide Research & Scholarship

Browsing "Medicine publications" by Author Eadie, L.N.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 11 of 11
PreviewIssue DateTitleAuthor(s)
2022Case Report: Precision Medicine Target Revealed by In Vitro Modeling of Relapsed, Refractory Acute Lymphoblastic Leukemia From a Child With NeurofibromatosisHeatley, S.L.; Page, E.C.; Eadie, L.N.; McClure, B.J.; Rehn, J.; Yeung, D.T.; Osborn, M.; Revesz, T.; Kirby, M.; White, D.L.
2023Case report: Rare case of donor cell-derived T-cell acute lymphoblastic leukaemia in a female patient after receiving an allo-transplant from her male siblingEadie, L.N.; Rehn, J.A.; Schutz, C.E.; Heatley, S.L.; Kutyna, M.M.; Hiwase, D.K.; White, D.L.; Yeung, D.T.
2023Case Report: Rare IKZF1 Gene Fusions Identified in Neonate with Congenital KMT2A-Rearranged Acute Lymphoblastic LeukemiaEadie, L.N.; Rehn, J.A.; Breen, J.; Osborn, M.P.; Jessop, S.; Downes, C.E.J.; Heatley, S.L.; McClure, B.J.; Yeung, D.T.; Revesz, T.; Saxon, B.; White, D.L.
2021Constitutive JAK/STAT signaling is the primary mechanism of resistance to JAKi in TYK2-rearranged acute lymphoblastic leukemiaTavakoli Shirazi, P.; Eadie, L.N.; Page, E.C.; Heatley, S.L.; Bruning, J.B.; White, D.L.
2022Exploring the oncogenic and therapeutic target potential of the MYB-TYK2 fusion gene in B-cell acute lymphoblastic leukemiaShirazi, P.T.; Eadie, L.N.; Heatley, S.L.; Page, E.C.; François, M.; Hughes, T.P.; Yeung, D.; White, D.L.
2022HMGN1 plays a significant role in CRLF2 driven Down Syndrome leukemia and provides a potential therapeutic target in this high-risk cohortPage, E.C.; Heatley, S.L.; Eadie, L.N.; McClure, B.J.; de Bock, C.E.; Omari, S.; Yeung, D.T.; Hughes, T.P.; Thomas, P.Q.; White, D.L.
2021In-vitro modeling of TKI resistance in the high-risk B-cell acute lymphoblastic leukemia fusion gene RANBP2-ABL1 - implications for targeted therapyHeatley, S.L.; Asari, K.; Schutz, C.E.; Leclercq, T.M.; McClure, B.J.; Eadie, L.N.; Hughes, T.P.; Yeung, D.T.; White, D.L.
2019KMT2A rearranged acute lymphoblastic leukaemia: unravelling the genomic complexity and heterogeneity of this high-risk diseaseForgione, M.O.; McClure, B.J.; Eadie, L.N.; Yeung, D.T.; White, D.L.
2020MLLT10 rearranged acute leukemia: incidence, prognosis and possible therapeutic strategiesForgione, M.O.; McClure, B.J.; Yeung, D.T.; Eadie, L.N.; White, D.L.
2022Rascall: Rapid (Ra) screening (Sc) of RNA-seq data for prognostically significant genomic alterations in acute lymphoblastic leukaemia (ALL)Rehn, J.; Mayoh, C.; Heatley, S.L.; McClure, B.J.; Eadie, L.N.; Schutz, C.; Yeung, D.T.; Cowley, M.J.; Breen, J.; White, D.L.; Gartenhaus, R.B.
2023The acquisition order of leukemic drug resistance mutations is directed by the selective fitness associated with each resistance mechanismLeow, B.C.S.; Kok, C.H.; Yeung, D.T.; Hughes, T.P.; White, D.L.; Eadie, L.N.
Showing results 1 to 11 of 11